Yanhong Deng
Clinical trials sponsored by Yanhong Deng, explained in plain language.
-
New combo could spare rectal cancer patients from radiation side effects
Disease control Recruiting nowThis phase 3 trial tests whether a stronger chemotherapy regimen plus a targeted drug (bevacizumab) can replace standard chemoradiation for high-risk locally advanced rectal cancer. About 582 adults will be randomly assigned to one of two treatments. The goal is to see if the new…
Phase: PHASE3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug cocktail aims to slow advanced colon cancer in asian patients
Disease control Recruiting nowThis phase 3 trial tests whether a stronger chemotherapy combination (mFOLFOXIRI) plus bevacizumab works better than a standard combo (mFOLFOX-6) plus bevacizumab for people with advanced colorectal cancer that cannot be removed by surgery. The study focuses on Asian patients, wh…
Phase: PHASE3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated May 08, 2026 12:01 UTC